Live Quote · NASDAQJUNSHealthcare· Biotechnology

Jupiter Neurosciences, Inc.

$0.22 3.72%(+$0.01)
TickerSpark Score
40/100
Weak
47
Valuation
60
Profitability
15
Growth
48
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a JUNS research report →

52-Week Range2% of range
Low
$0.17
Current
$0.22
High
$3.33
Company Overviewwww.jupiterorphan.com

About the company

Jupiter Neurosciences, Inc. is a pharmaceutical company engaged in clinical-stage research and development. Its primary focus is on advancing a resveratrol-based platform product, with the main objective of addressing neuro-inflammation.

CEO
Christer Rosen
IPO
2022
Employees
4
HQ
Jupiter, FL, US

Price Chart

-81.26% · this period
$2.97$1.59$0.20Jul 02Dec 31Jul 02
Valuation
Market Cap
$8.11M
P/E
-0.82
P/S
200.41
P/B
-2.82
EV/EBITDA
-1.18
Div Yield
0.00%
Profitability
Gross Margin
89.22%
Op Margin
-23075.85%
Net Margin
-22690.83%
ROE
1140.91%
ROIC
-455.42%
Growth & Income
Revenue
$21.80K · 0.00%
Net Income
$-8,644,897 · -254.35%
EPS
$-0.25 · -194.81%
Op Income
$-8,908,721
FCF YoY
-38.42%
Performance & Tape
52W High
$3.33
52W Low
$0.17
50D MA
$0.29
200D MA
$0.80
Beta
1.71
Avg Volume
7.09M

Get TickerSpark's AI analysis on JUNS

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 29, 26Philipson Tomas Janother536,428
Jun 26, 26Philipson Tomas Janother0
Jun 2, 26Brady Allison Wother100,000
Jun 2, 26Elmasri Saleemother525,565
Jun 2, 26ROSEN CHRISTERother747,783
Jun 2, 26Hemmerly Nicholas H.other100,000
Jun 2, 26Kampf Julie B.other100,000
Jun 2, 26Silva Alison D.other1,027,304
Jun 2, 26Hayward Marshall A.other259,231
Jun 2, 26Weis Holgerother100,000
Coverage · JUNS

Our JUNS coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on JUNS yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate JUNS report →
Internal Compare

Similar companies

Peers in the same neighborhood.